The use of amphetamine induced stereotyped behaviour as a model for the experimental evaluation of antiparkinson agents.
D000661:Amphetamine; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001522:Behavior, Animal / Q000187:drug effects*; D004357:Drug Synergism; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005189:False Positive Reactions; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D008297:Male; D008954:Models, Biological; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology
D000928:Antidepressive Agents; D000978:Antiparkinson Agents; D006634:Histamine H1 Antagonists; D008996:Monoamine Oxidase Inhibitors; D010276:Parasympatholytics; D013565:Sympatholytics; D014149:Tranquilizing Agents; D009020:Morphine; D000661:Amphetamine